Dimitrios Farmakis
University of Cyprus
Publications 265
#1Dimitrios Farmakis (UCY: University of Cyprus)H-Index: 40
#2Piergiuseppe Agostoni (University of Milan)H-Index: 43
Last.John Parissis (UoA: National and Kapodistrian University of Athens)H-Index: 42
view all 36 authors...
Abstract Inotropes aim at increasing cardiac output by enhancing cardiac contractility. They constitute the third pharmacological pillar in the treatment of patients with decompensated heart failure, the other two being diuretics and vasodilators. Three classes of parenterally administered inotropes are currently indicated for decompensated heart failure, (i) the beta adrenergic agonists, including dopamine and dobutamine and also the catecholamines epinephrine and norepinephrine, (ii) the phosp...
Colorectal cancer (CRC) is the third most common malignancy in men and the second in women and the fourth cause of cancer death. Survival rates decrease greatly according to the stage of the disease at the time of diagnosis. Approximately 50% of CRC patients will develop metastatic disease (mCRC) with survival and prognosis depending on the timing of metastatic development, and the localization and number of metastatic sites. The overall survival of patients with mCRC has been significantly impr...
#1Kalliopi Keramida (UCY: University of Cyprus)H-Index: 2
#2John Parissis (UoA: National and Kapodistrian University of Athens)H-Index: 42
Last.Dimitrios Farmakis (UCY: University of Cyprus)H-Index: 40
view all 4 authors...
Cardiogenic shock (CS) is increasingly recognized in patients with malignancies, while cancer is independently associated with worse prognosis in CS. A number of conditions may lead to CS in cancer, including acute coronary syndromes, cardiomyopathy, takotsubo syndrome, myocarditis, pulmonary embolism, tamponade, and cardiac herniation. In these conditions, CS may be related to cancer itself or to cancer therapy, including surgery, chemotherapy, or radiotherapy. Given the significantly improved ...
#1Panagiotis Efentakis (University of Mainz)H-Index: 9
#2Aimilia Varela (Academy of Athens)H-Index: 8
Last.Ioanna Andreadou (UoA: National and Kapodistrian University of Athens)H-Index: 32
view all 18 authors...
#1Petar M. Seferovic (University of Belgrade)H-Index: 41
#2Marija M. Polovina (University of Belgrade)H-Index: 11
Last.Carsten Tschöpe (Charité)H-Index: 46
view all 47 authors...
[Seferovic, Petar M.; Polovina, Marija; Krljanac, Gordana; Maksimovic, Ruzica; Pavlovic, Sinisa U.; Ristic, Arsen D.; Asanin, Milika; Seferovic, Jelena R.] Univ Belgrade, Fac Med, 8 Koste Todorovica, Belgrade 11000, Serbia. [Seferovic, Petar M.; Kanjuh, Vladimir] Serbian Acad Arts & Sci, Belgrade, Serbia. [Polovina, Marija; Krljanac, Gordana; Milinkovic, Ivan; Ristic, Arsen D.; Asanin, Milika] Clin Ctr Serbia, Dept Cardiol, Belgrade, Serbia. [Bauersachs, Johann] Med Sch Hannover, Dept Cardiol & ...
BackgroundB-thalassemia carrier state or thalassemia minor confers cardiovascular protection through favorable lipidemic and blood pressure profile. However, its impact on inflammatory status—a common denominator of the above conditions—has not been addressed.MethodsWe investigated a wide range of i